Analysis of regulatory sequences in exosomal DNA of NANOGP8

PLoS One. 2023 Jan 25;18(1):e0280959. doi: 10.1371/journal.pone.0280959. eCollection 2023.

Abstract

Exosomes participate in intercellular communication by transporting functionally active molecules. Such cargo from the original cells comprising proteins, micro-RNA, mRNA, single-stranded (ssDNA) and double-stranded DNA (dsDNA) molecules pleiotropically transforms the target cells. Although cancer cells secrete exosomes carrying a significant level of DNA capable of modulating oncogene expression in a recipient cell, the regulatory mechanism is unknown. We have previously reported that cancer cells produce exosomes containing NANOGP8 DNA. NANOGP8 is an oncogenic paralog of embryonic stem cell transcription factor NANOG and does not express in cells since it is a pseudogene. However, in this study, we evaluated NANOGP8 expression in glioblastoma multiforme (GBM) tissue from a surgically removed brain tumor of a patient. Significantly higher NANOGP8 transcription was observed in GBM cancer stem cells (CSCs) than in GBM cancer cells or neural stem cells (NSCs), despite identical sequences of NANOGP8-upstream genomic region in all the cell lines. This finding suggests that upstream genomic sequences of NANOGP8 may have environment-dependent promoter activity. We also found that the regulatory sequences upstream of exosomal NANOGP8 GBM DNA contain multiple core promoter elements, transcription factor binding sites, and segments of human viruses known for their oncogenic role. The exosomal sequence of NANOGP8-upstream GBM DNA is different from corresponding genomic sequences in CSCs, cancer cells, and NSCs as well as from the sequences reported by NCBI. These sequence dissimilarities suggest that exosomal NANOGP8 GBM DNA may not be a part of the genomic DNA. Exosomes possibly acquire this DNA from other sources where it is synthesized by an unknown mechanism. The significance of exosome-bestowed regulatory elements in the transcription of promoter-less retrogene such as NANOGP8 remains to be determined.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • DNA
  • Glioblastoma* / genetics
  • Glioblastoma* / pathology
  • Humans
  • MicroRNAs*
  • Nanog Homeobox Protein / genetics
  • Nanog Homeobox Protein / metabolism
  • Oncogenes

Substances

  • Nanog Homeobox Protein
  • MicroRNAs
  • DNA

Grants and funding

Funding: This research was funded by Florida health department grant, Ed and Ethel Moore Alzheimer Research Grant Number: University of Central Florida (7AZ11), Principal Investigator: Kiminobu Sugaya, PhD, Project Title: Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer’s disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.